Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
10.07
-0.20 (-1.95%)
At close: Oct 19, 2026, 4:00 PM EDT
10.02
-0.05 (-0.50%)
After-hours: Oct 19, 2026, 6:06 PM EDT
Ginkgo Bioworks Holdings Revenue
Ginkgo Bioworks Holdings had revenue of $20.16M in the quarter ending June 30, 2026, a decrease of -48.49%. This brings the company's total for the last twelve months to $111.86M, down -51.54% year-over-year. In the year 2025, Ginkgo Bioworks Holdings had annual revenue of $170.16M, down -25.06%. That makes Ginkgo Bioworks Holdings the 20,543rd largest company in the world by revenue and 3,121st in the United States.
Revenue (ttm)
$111.86M
Revenue Growth
-51.54%
P/S Ratio
5.21
Revenue / Employee
$273,033
Employees
485
Market Cap
678.12M
Revenue by Segment
- Cell Engineering 132.75M 78.0%
- Biosecurity Service 37.41M 22.0%
Fiscal year ended Dec 31, 2025 See the full Ginkgo Bioworks Holdings breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 170.16M | -56.89M | -25.06% |
| Dec 31, 2024 | 227.04M | -24.41M | -9.71% |
| Dec 31, 2023 | 251.46M | -226.25M | -47.36% |
| Dec 31, 2022 | 477.71M | 163.87M | 52.21% |
| Dec 31, 2021 | 313.84M | 237.18M | 309.40% |
| Dec 31, 2020 | 76.66M | 22.47M | 41.48% |
| Dec 31, 2019 | 54.18M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Pharming Group | 366.48M |
| Apnimed | 115.12M |
| 4D Molecular Therapeutics | 92.01M |
| Lexicon Pharmaceuticals | 41.47M |
| OmniAb | 38.46M |
| Adlai Nortye Group | 18.06M |
| Inventiva | 2.81M |
DNA News
- 6 days ago - Ginkgo Bioworks price target raised to $11 from $9 at TD Cowen - TheFly
- 11 days ago - Ginkgo Bioworks to provide autonomous lab access to NSF X-Labs researchers - TheFly
- 11 days ago - Ginkgo Bioworks to Provide Autonomous Lab Access to NSF X-Labs Researchers, Contributing Cloud Lab Time and Protein Testing Services to $1.5 Billion Breakthrough Science Program - Business Wire
- 11 days ago - Ginkgo Bioworks announces integration of Araceli Endeavor - TheFly
- 11 days ago - Araceli Biosciences and Ginkgo Bioworks Bring Cellular Imaging at Scale to Nebula's Lab-in-the-Loop - PRNewsWire
- 20 days ago - Ginkgo Bioworks, Apheris announce kick off of Antibody Developability Consortium - TheFly
- 4 weeks ago - Ginkgo Bioworks announces partnership with Lilly TuneLab - TheFly
- 4 weeks ago - Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab Data - Business Wire